Silvia Pittalis

ORCID: 0000-0002-4350-2452
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral Infections and Outbreaks Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Disaster Response and Management
  • HIV/AIDS drug development and treatment
  • Viral Infections and Vectors
  • Surgical site infection prevention
  • COVID-19 epidemiological studies
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Cardiac, Anesthesia and Surgical Outcomes
  • SARS-CoV-2 detection and testing
  • Tuberculosis Research and Epidemiology
  • Poxvirus research and outbreaks
  • Zoonotic diseases and public health
  • Urinary Tract Infections Management
  • HIV/AIDS Research and Interventions
  • Mosquito-borne diseases and control
  • Respiratory viral infections research
  • Bacillus and Francisella bacterial research
  • Hepatitis C virus research
  • Respiratory Support and Mechanisms
  • Herpesvirus Infections and Treatments
  • Tissue Engineering and Regenerative Medicine
  • HIV/AIDS oral health manifestations

University of Rome Tor Vergata
2024

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
2013-2023

Istituti di Ricovero e Cura a Carattere Scientifico
2006-2022

Fundación Juan March
2012

Regione Puglia
2011

University of Padua
2003

Since May 2022, an outbreak of monkeypox has been ongoing in non-endemic countries. We report four cases Italy young adult men reporting condomless sexual intercourse. The patients are good clinical condition with no need for specific antiviral drugs. Biological samples from seminal fluid were positive viral DNA. For many other viruses found semen there is evidence transmission. possibility transmission virus needs to be investigated.

10.2807/1560-7917.es.2022.27.22.2200421 article EN cc-by Eurosurveillance 2022-06-02
Fabrizio Albarello Elisa Pianura Federica Di Stefano Massimo Cristofaro Ada Petrone and 93 more Luisa Marchioni Claudia Palazzolo Vincenzo Schininà Emanuele Nicastri Nicola Petrosillo Paolo Campioni Eskild Petersen Alimuddin Zumla Giuseppe Ippolito Maria Alessandra Abbonizio Chiara Agrati Fabrizio Albarello Gioia Amadei Alessandra Amendola Mario Antonini Maria Raffaella Barbaro Barbara Bartolini Martina Benigni Nazario Bevilacqua Licia Bordi Veronica Bordoni Marta Branca Paolo Campioni Maria Rosaria Capobianchi Cinzia Caporale Ilaria Caravella Fabrizio Carletti Concetta Castilletti Roberta Chiappini Carmine Ciaralli Francesca Colavita Angela Corpolongo Massimo Cristofaro Salvatore Curiale Alessandra D’Abramo Cristina Dantimi Alessia De Angelis Giada De Angelis Rachele Di Lorenzo Federica Di Stefano Federica Ferraro Lorena Fiorentini Andrea Frustaci Paola Gallì Gabriele Garotto Maria Letizia Giancola Filippo Giansante Emanuela Giombini Maria Cristina Greci Giuseppe Ippolito Eleonora Lalle Simone Lanini Daniele Lapa Luciana Lepore Andrea Lucia Franco Lufrani Manuela Macchione Alessandra Marani Luisa Marchioni Andrea Mariano Maria Cristina Marini Micaela Maritti Giulia Matusali Silvia Meschi Francesco Messina Chiara Montaldo Silvia Murachelli Emanuele Nicastri Roberto Noto Claudia Palazzolo Emanuele Pallini Virgilio Passeri Federico Pelliccioni Antonella Petrecchia Ada Petrone Nicola Petrosillo Elisa Pianura Maria Pisciotta Silvia Pittalis Costanza Proietti Vincenzo Puro Gabriele Rinonapoli Martina Rueca Alessandra Sacchi Francesco Sanasi Carmen Santagata Silvana Scarcia Vincenzo Schininà Paola Scognamiglio Laura Scorzolini Giulia Valeria Stazi Francesco Vaia Francesco Vairo Maria Beatrice Valli

IntroductionSeveral recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar those seen previously in SARS-CoV and MERS-CoV infected patients.ObjectiveWe present some remarkable the first two patients identified Italy with COVID-19 infection travelling from Wuhan, China. The follow-up X-Rays CT scans was also included, showing a progressive adult respiratory distress syndrome...

10.1016/j.ijid.2020.02.043 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-02-26
Massimo Tempestilli Priscilla Caputi Valeria Avataneo Stefania Notari Olindo Forini and 95 more Laura Scorzolini Luisa Marchioni Tommaso Ascoli Bartoli Concetta Castilletti Eleonora Lalle Maria Rosaria Capobianchi Emanuele Nicastri Antonio D’Avolio Giuseppe Ippolito Chiara Agrati Maria Alessandra Abbonizio Chiara Agrati Fabrizio Albarello Gioia Amadei Alessandra Amendola Andrea Antinori Mario Antonini Maria Raffaella Barbaro Barbara Bartolini Martina Benigni Nazario Bevilacqua Licia Bordi Veronica Bordoni Marta Branca Paolo Campioni Maria Rosaria Capobianchi Cinzia Caporale Ilaria Caravella Fabrizio Carletti Rita Casetti Concetta Castilletti Roberta Chiappini Carmine Ciaralli Eleonora Cimini Francesca Colavita Angela Corpolongo Massimo Cristofaro Salvatore Curiale Alessandra D’Abramo Cristina Dantimi Alessia De Angelis Giada De Angelis Rachele Di Lorenzo Federica Di Stefano Gianpiero D’Offizi Federica Ferraro Lorena Fiorentini Andrea Frustaci Paola Gallì Gabriele Garotto Maria Letizia Giancola Filippo Giansante Emanuela Giombini Germana Grassi Maria Cristina Greci Giuseppe Ippolito Eleonora Lalle Simone Lanini Daniele Lapa Luciana Lepore Andrea Lucía Franco Lufrani Manuela Macchione Alessandra Marani Luisa Marchioni Andrea Mariano Maria Cristina Marini Micaela Maritti Giulia Matusali Silvia Meschi Francesco Messina Chiara Montaldo Silvia Murachelli Emanuele Nicastri Roberto Noto Claudia Palazzolo Emanuele Pallini Fabrizio Palmieri Virgilio Passeri Federico Pelliccioni Antonella Petrecchia Ada Petrone Nicola Petrosillo Elisa Pianura Maria Pisciotta Silvia Pittalis Costanza Proietti Vincenzo Puro Gabriele Rinonapoli Martina Rueca Alessandra Sacchi Francesco Sanasi Carmen Santagata Silvana Scarcia Vincenzo Schininà

Abstract Background Remdesivir is a prodrug of the nucleoside analogue GS-441524 and under evaluation for treatment SARS-CoV-2-infected patients. Objectives To evaluate pharmacokinetics remdesivir in plasma, bronchoalveolar aspirate (BAS) CSF two critically ill COVID-19 Methods was administered at 200 mg loading dose on first day followed by 12 days 100 Blood samples were collected immediately after (C0) 1 (C1) 24 h (C24) intravenous administration 3 until 9. BAS Days 4, 7 9 from both...

10.1093/jac/dkaa239 article EN other-oa Journal of Antimicrobial Chemotherapy 2020-05-27
Serena Vita Virginia Di Bari Angela Corpolongo Delia Goletti Joaquı́n M. Espinosa and 87 more Sebastiano Petracca Fabrizio Palmieri Emanuele Nicastri Abbonizio Chiara Agrati Fabrizio Albarello Gioia Amadei Alessandra Amendola Mario Antonini Maria Raffaella Barbaro Barbara Bartolini Martina Benigni Nazario Bevilacqua Licia Bordi Veronica Bordoni Marta Branca Paolo Campioni Maria Rosaria Capobianchi Cinzia Caporale Ilaria Caravella Fabrizio Carletti Concetta Castilletti Roberta Chiappini Carmine Ciaralli Francesca Colavita Angela Corpolongo Massimo Cristofaro Salvatore Curiale Alessandra D’Abramo Cristina Dantimi Alessia De Angelis Giada De Angelis Rachele Di Lorenzo Federica Di Stefano Federica Ferraro Lorena Fiorentini Andrea Frustaci Paola Gallì Gabriele Garotto Maria Letizia Giancola Filippo Giansante Emanuela Giombini Maria Cristina Greci Giuseppe Ippolito Eleonora Lalle Simone Lanini Daniele Lapa Luciana Lepore Andrea Lucía Franco Lufrani Manuela Macchione Alessandra Marani Luisa Marchioni Andrea Mariano Maria Cristina Marini Micaela Maritti Giulia Matusali Silvia Meschi Francesco Messina Chiara Montaldo Silvia Murachelli Emanuele Nicastri Roberto Noto Claudia Palazzolo Emanuele Pallini Virgilio Passeri Federico Pelliccioni Antonella Petrecchia Ada Petrone Nicola Petrosillo Elisa Pianura Maria Pisciotta Silvia Pittalis Costanza Proietti Vincenzo Puro Gabriele Rinonapoli Martina Rueca Alessandra Sacchi Francesco Sanasi Carmen Santagata Silvana Scarcia Vincenzo Schininà Paola Scognamiglio Laura Scorzolini Giulia Stazi Francesco Vaia Francesco Vairo Maria Beatrice Valli

We report two cases of Corona Virus Disease-19 (COVID-19) in patients with Down Syndrome (DS) and describe the identification, diagnosis, clinical course management infection. Syndrome, which is caused by trisomy 21, characterized immune dysregulation, anatomical differences upper respiratory tract higher rate comorbidities. All these risk factors can contribute to more severe presentations COVID-19 this population. It essential raise awareness relevance SARS-COV-2 infection DS patients, as...

10.1016/j.ijid.2020.11.188 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-11-30

Abstract Background The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases risk for Leishmania -infected people develop visceral illness. Case presentation Three infantum in corticosteroid (CS)-treated patients are reported: an isolated lingual a farmer treated CS asthma, severe cutaneous lesions woman...

10.1186/1471-2334-6-177 article EN cc-by BMC Infectious Diseases 2006-12-01

Transmitted drug resistance (TDR) is still a critical aspect for the management of individuals living with HIV-1. Thus, its evaluation crucial to optimize HIV care.

10.1093/jac/dkae189 article EN cc-by Journal of Antimicrobial Chemotherapy 2024-07-19

There is still wide variability in surgical antimicrobial prophylaxis (SAP) practice by different teams and specialties, with potential impact on adverse events the emergence of antibiotic resistance.We assessed SAP appropriateness a regional prospective multicenter study basis agreement Surgical Care Improvement Project indicators (SCIP-Inf) Italian guidelines (GL).Prophylaxis was administered 2,664 2,835 procedures (94%): In 2,346 2,468 (95%) as indicated 318 367 (86.6%) which they were...

10.1089/sur.2012.189 article EN Surgical Infections 2013-07-12

Transmitted drug-resistance (TDR) remains a critical aspect for the management of HIV-1-infected individuals. Thus, studying dynamics TDR is crucial to optimize HIV care. In total, 4323 HIV-1 protease/reverse-transcriptase sequences from drug-naive individuals diagnosed in north and central Italy between 2000 2014 were analysed. was evaluated over time. Maximum-likelihood Bayesian phylogenetic trees with bootstrap Bayesian-probability supports defined transmission clusters. Most males...

10.1093/jac/dkx231 article EN Journal of Antimicrobial Chemotherapy 2017-06-15

Action on social determinants is a main component of the World Health Organization End Tuberculosis (TB) Strategy. The aim study was to collect information socioeconomic characteristics and biomedical risk factors in migrant TB patients Italy compare it with data collected among Italian patients. A cross-sectional conducted aged ≥18 years over 12-months enrolment period 12 major hospitals. Information education, employment, housing income collected, European Union Statistics Income Living...

10.1371/journal.pone.0189425 article EN cc-by PLoS ONE 2017-12-18

Torquetenovirus (TTV) is the most abundant component of human blood virome and its replication controlled by a functioning immune system. In this study, TTV was evaluated in 21 people with acute HIV infection (AHI) reconstitution following antiretroviral therapy (ART). PBMC-associated HIV-1 DNA, as well plasma RNA, were measured real-time PCR. CD4 CD8 differentiation, activation, exhaustion, senescence phenotypes analyzed flow cytometry. Thirteen healthy donors (HD) twenty-eight chronically...

10.3390/v15091931 article EN cc-by Viruses 2023-09-15

Molecular investigation of primary HIV infections (PHI) is crucial to describe current dynamics transmission. Aim the study was investigate transmission clusters (TC) in PHI referred during years 2013–2020 National Institute for Infectious Diseases Rome (INMI), that Lazio regional AIDS reference centre, and factors possibly associated with inclusion TC. These were identified by phylogenetic analysis, based on population sequencing pol; a more depth analysis performed TC B subtype, using...

10.3390/v13020176 article EN cc-by Viruses 2021-01-25

HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being positive. Among them 390 were current PrEP users, and 131 had taken in the past. Of 958 individuals consenting testing, six newly diagnosed with HIV. Two patients symptomatic primary infection. None of ever PrEP. Mpox vaccination represents an important opportunity for counselling about risk reduction

10.2807/1560-7917.es.2022.27.48.2200890 article EN cc-by Eurosurveillance 2022-12-01

Sampling Surfaces for Ebola Virus Persistence After Cleaning Procedures in High-Level Isolation Settings: The Experience With 2 Patients at the Lazzaro Spallanzani National Institute Infectious Diseases - Volume 37 Issue 6

10.1017/ice.2016.46 article EN Infection Control and Hospital Epidemiology 2016-03-10
Coming Soon ...